Irinotecan hydrochloride
NDC 70700-170, Irinotecan hydrochloride, injection, from Xiromed LLC.
- Product NDC
- 70700-170
- Status
- Listed
- Labeler
- Xiromed LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212993
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70700-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IRINOTECAN HYDROCHLORIDE20 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70700-170-22 | 70700017022 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70700-170-22) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b26e5d27-dba5-7538-9e7b-48b358998cbbMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70700-170
Use it
Look up 70700-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70700-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70700-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.